Italy artificial intelligence (AI) in medical Imaging market size was valued at $36 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 34.9% from 2022 to 2030 and will reach $395 Mn. The market is segmented by AI technology, solution, modality, application, and end User. Due to developments in AI and machine learning algorithms that are enabling the creation of more precise and effective medical imaging software, the Italy Artificial Intelligence (AI) in the Medical Imaging market will expand. Some of the key players in this market are Canon Medical Systems, Barco, Medtronic, GE Healthcare, Siemens Healthineers, Hologic, Koninklijke Philips, Fujifilm, Brainomix, Quibim, and others.
Market Executive Summary
Italy artificial intelligence (AI) in medical Imaging market size was valued at $36 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 34.9% from 2022 to 2030 and will reach $ 395. Italy's health expenditure on AI technology is not readily available. However, according to a report by Market Research Future, the Italy Artificial Intelligence (AI) in Medical Imaging market is expected to grow at a CAGR of 35.3% from 2019 to 2025.
Accurate illness diagnosis and treatment are made possible by medical imaging, which is a crucial component of healthcare. Technology and digital data have revolutionised the photographic industry. As a result, over the past several years, the adoption of AI-based solutions in the healthcare industry has expanded. In the future years, these factors are expected to propel the market for artificial intelligence in medical imaging.
Palpation was one of the few imaging diagnostic techniques accessible in the past; however, today, there are several techniques available, including x-ray, CT, MRI, and (3D) ultrasound. The market for AI in medical imaging is supported by the use of AI to enhance accuracy, speed up interpretation, and decrease repetition for radiologists.
There are various regions in Italy where Artificial Intelligence (AI) is being used in Medical Imaging. For example, in the region of Lombardy, the IRCCS San Raffaele Scientific Institute has implemented an AI-powered image analysis system for early detection of breast cancer. In the Emilia-Romagna region, a research project called PECULIAR is being conducted to develop AI-based tools for precision oncology. The University of Naples Federico II in the Campania region is using AI algorithms to analyze brain MRI images and predict the progression of Alzheimer's disease. Similarly, the University of Catania in Sicily is working on an AI system to detect lung nodules from CT scans. Therefore, the demand for AI in medical imaging in Italy will increase in the coming years.
Market Growth Drivers
The market drivers for Artificial Intelligence (AI) in Medical Imaging in Italy include the need to improve diagnostic accuracy and efficiency, reduce healthcare costs, and improve patient outcomes. AI technology can help in early detection of diseases, identification of subtle changes in medical images, and improving the accuracy of diagnoses. Additionally, the increasing prevalence of chronic diseases and the aging population in Italy are also driving the demand for AI in medical imaging.
Market restraints:
The major restraints for the AI in medical imaging market in Italy include concerns related to data privacy and security, lack of awareness among healthcare professionals about AI technology, and regulatory challenges. The implementation of AI technology requires significant changes in the current healthcare infrastructure and processes, and this can be a barrier to adoption. The lack of standardization and interoperability of AI systems is also a major challenge in the Italian market.
Key Players
Some of the leading companies in Italy's AI in Medical Imaging market include Esaote S.p.A., Brainance S.r.l., and Aiforia Technologies Oy. Esaote S.p.A. is a medical technology company that develops and produces diagnostic imaging systems, including MRI, ultrasound, and X-ray systems. Brainance S.r.l. is a start-up that develops AI algorithms to aid in the diagnosis of neurological disorders using MRI scans. Aiforia Technologies Oy is a Finnish company that provides AI-powered image analysis software for pathology and medical research.
The main regulatory body for healthcare in Italy is the Italian Ministry of Health, which oversees the development and implementation of policies related to healthcare, medical devices, and pharmaceuticals. In addition, the Italian Medicines Agency (AIFA) is responsible for regulating medical devices and pharmaceuticals in the country.
The use of AI in medical imaging falls under the broader umbrella of medical devices, which are regulated by the European Union (EU) through the Medical Device Regulation (MDR). The MDR applies to all medical devices, including those that incorporate AI or machine learning technologies, and requires that they undergo a rigorous process of testing and certification before they can be marketed and sold in the EU.
In addition, the General Data Protection Regulation (GDPR) applies to the use of personal data in healthcare, including data used in medical imaging. The GDPR establishes strict rules for the collection, use, and storage of personal data, including requirements for informed consent, data security, and the right to be forgotten. Overall, while there are no specific regulations in Italy that address the use of AI in medical imaging, healthcare providers and medical device manufacturers must comply with EU regulations and the GDPR when developing and implementing AI technologies in healthcare. It is also important to note that regulations and policies are subject to change over time, and healthcare professionals and industry stakeholders should stay up-to-date on any new developments or updates to existing regulations.
1. Report Description of the Italy Artificial Intelligence (AI) in Medical Imaging Market
1.1 Research Scope and Assumption
1.2 Objective of the study
1.3 Research Methodology
1.4 Reason to buy the report
2. Italy Artificial Intelligence (AI) in Medical Imaging Market Executive Summary
2.1 Italy Artificial Intelligence (AI) in Medical Imaging Market – Market Overview
2.2 Market Size, Growth Prospects, and Key findings
3. Market Dynamics of the Italy Artificial Intelligence (AI) in Medical Imaging Market
3.1 Market Growth Drivers Analysis
3.2 Market Restraints Analysis
4. Italy Artificial Intelligence (AI) in Medical Imaging Market Segmentation
4.1 By AI Technology
4.1.1 Deep Learning
4.1.2 Natural Language Processing (NLP)
4.1.3 Others
4.2 By Solution
4.2.1 Software Tools/ Platform
4.2.2 Services
4.2.3 Integration
4.2.4 Deployment
4.3 By Modality
4.3.1 CT scan
4.3.2 MRI
4.3.3 X-rays
4.3.4 Ultrasound Imaging
4.3.5 Nuclear Imaging
4.4 By Application
4.4.1 Digital Pathology
4.4.2 Oncology
4.4.3 Cardiovascular
4.4.4 Neurology
4.4.5 Lung (Respiratory System)
4.4.6 Breast (Mammography)
4.4.7 Liver (GI)
4.4.8 Oral Diagnostics
4.4.9 Other
4.5 By End Use
4.5.1 Hospital and Healthcare Providers
4.5.2 Patients
4.5.3 Pharmaceuticals and Biotechnology Companies
4.5.4 Healthcare Payers
4.5.5 Others
5. Italy Artificial Intelligence (AI) in Medical Imaging Market Share
5.1 Market Analysis, Insights, and Forecast – By Revenue
6. Competitive Landscape
6.1 Major Top Market Players
7. Key Company Profiles
7.1 Company 1
7.1.1 Overview
7.1.2 Financial Performance
7.1.3 Product & Services
7.1.4 Strategic initiatives
7.2 Company 2
7.2.1 Overview
7.2.2 Financial Performance
7.2.3 Product & Services
7.2.4 Strategic initiatives
7.3 Company 3
7.3.1 Overview
7.3.2 Financial Performance
7.3.3 Product & Services
7.3.4 Strategic initiatives
7.4 Company 4
7.4.1 Overview
7.4.2 Financial Performance
7.4.3 Product & Services
7.4.4 Strategic initiatives
7.5 Company 5
7.5.1 Overview
7.5.2 Financial Performance
7.5.3 Product & Services
7.5.4 Strategic initiatives
8. Healthcare Policies and Regulatory Landscape
8.1 Healthcare Policies in the Italy
8.2 Regulatory Framework in the Italy
8.3 Pricing & Reimbursement Scenario in Italy Artificial Intelligence (AI) in Medical Imaging Market
9. Factors Driving Future Growth
9.1 New Trends and Development Italy Artificial Intelligence (AI) in Medical Imaging Market
9.2 Future Opportunities
10. Strategic Recommendations
By AI Technology
By Solution
By Modality
When compared to CT scans, magnetic resonance imaging can produce pictures that are free of imperfections. Due to its efficiency in obtaining details and better-quality pictures of soft tissues, the MRI is frequently seen as a superior alternative to X-rays. Utilizing optical coherence tomography, three-dimensional interactions between the retina and membranes are made possible in order to control the vitreoretinal disease.
By Application
The market is dominated by the digital pathology segment, which can be linked to pathologists' rising productivity. A validation tool for image analytics is provided by digital pathology, helping pathologists process more slides in less time. This facilitates early illness identification and quicker therapy initiation. AI and digital pathology also assist doctors in making patient-centered decisions. The oncology market is also expected to grow in popularity as more individuals become aware of cancer and its increased incidence in the public. Personalized therapy is made possible by artificial intelligence algorithms that identify and comprehend the nature of malignancies. The second section focUses on AI-driven diagnostic imaging for the heart, brain, breast, and mouth.
By End Use
The market is dominated by the healthcare sector. This is becaUse hospitals are widely dispersed and accessible; hence, many patients like hospitals. The market for medical imaging AI is also anticipated to benefit from favorable reimbursement regulations. During the anticipated time, diagnostic centers are anticipated to grow in popularity. This may be attributable to elements including rising patient awareness and a desire for diagnostic procedures and tests, all of which are fueling the market's expansion. Due to its ease in providing high-quality medical facilities in remote places, particularly rural ones, the ambulatory category is expected to develop at a quicker CAGR throughout the projection period. The availability of qualified surgeons and a surplAustralia of the necessary equipment are contributing to the expansion of the hospital market. Government assistance in emerging nations is likely to boost hospital infrastructure and technologies throughout the forecast period, which is anticipated to caUse the hospital segment to see growth.
Insights10 will provide you with the reports within 10 key parameters which are:
Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.
Stage I: Market Data Collection
Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.
Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.
Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:
Stage II: Market Data Analysis and Statistical Model
Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.
Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.
The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.
The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.
Data Triangulation & Validation:
Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.
We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.
Stage III: Interpretation and Presentation
Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)
Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.
Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.
This report addresses
Need more?